BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24502545)

  • 1. Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models.
    Tiong HY; Huang P; Xiong S; Li Y; Vathsala A; Zink D
    Mol Pharm; 2014 Jul; 11(7):1933-48. PubMed ID: 24502545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of nephrotoxic compounds with embryonic stem-cell-derived human renal proximal tubular-like cells.
    Li Y; Kandasamy K; Chuah JK; Lam YN; Toh WS; Oo ZY; Zink D
    Mol Pharm; 2014 Jul; 11(7):1982-90. PubMed ID: 24495215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies.
    Wu H; Huang J
    Curr Drug Metab; 2018; 19(7):559-567. PubMed ID: 29119923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell- and biomarker-based assays for predicting nephrotoxicity.
    Huang JX; Blaskovich MA; Cooper MA
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1621-35. PubMed ID: 25382677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicologic Pathology Forum Opinion Paper*: Recommendations for a Tiered Approach to Nonclinical Mechanistic Nephrotoxicity Evaluation.
    Ennulat D; Ringenberg M; Frazier KS
    Toxicol Pathol; 2018 Aug; 46(6):636-646. PubMed ID: 30049250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney-on-a-Chip: A New Technology for Predicting Drug Efficacy, Interactions, and Drug-induced Nephrotoxicity.
    Lee J; Kim S
    Curr Drug Metab; 2018; 19(7):577-583. PubMed ID: 29521220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods.
    Kandasamy K; Chuah JK; Su R; Huang P; Eng KG; Xiong S; Li Y; Chia CS; Loo LH; Zink D
    Sci Rep; 2015 Jul; 5():12337. PubMed ID: 26212763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Review on Drug-Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation Approaches.
    Mody H; Ramakrishnan V; Chaar M; Lezeau J; Rump A; Taha K; Lesko L; Ait-Oudhia S
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):896-909. PubMed ID: 33025766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Induced Kidney Injury in the Elderly.
    Khan S; Loi V; Rosner MH
    Drugs Aging; 2017 Oct; 34(10):729-741. PubMed ID: 28815461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in predictive in vitro models of drug-induced nephrotoxicity.
    Soo JY; Jansen J; Masereeuw R; Little MH
    Nat Rev Nephrol; 2018 Jun; 14(6):378-393. PubMed ID: 29626199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children.
    Goswami E; Ogden RK; Bennett WE; Goldstein SL; Hackbarth R; Somers MJG; Yonekawa K; Misurac J
    Am J Health Syst Pharm; 2019 Oct; 76(22):1869-1874. PubMed ID: 31665764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication-Induced Nephrotoxicity in Older Patients.
    Fusco S; Garasto S; Corsonello A; Vena S; Mari V; Gareri P; Ruotolo G; Luciani F; Roncone A; Maggio M; Lattanzio F
    Curr Drug Metab; 2016; 17(6):608-25. PubMed ID: 27048182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic biomarkers for cytotoxic acute kidney injury.
    Vaidya VS; Bonventre JV
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):697-713. PubMed ID: 17014390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity: a rational approach to target cell injury in vitro in the kidney.
    Bach PH; Kwizera EN
    Xenobiotica; 1988 Jun; 18(6):685-98. PubMed ID: 3048003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrotoxins and nephrotoxic acute kidney injury.
    Uber AM; Sutherland SM
    Pediatr Nephrol; 2020 Oct; 35(10):1825-1833. PubMed ID: 31646405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening.
    Wilmer MJ; Ng CP; Lanz HL; Vulto P; Suter-Dick L; Masereeuw R
    Trends Biotechnol; 2016 Feb; 34(2):156-170. PubMed ID: 26708346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug-induced acute kidney injury].
    Derungs A
    Ther Umsch; 2015 Dec; 72(11-12):717-27. PubMed ID: 26654816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic Approach.
    Antognini N; Portman R; Dong V; Webb NJ; Chand DH
    Ther Innov Regul Sci; 2024 Mar; 58(2):286-302. PubMed ID: 38110788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Principles for the Prevention of Medication-Induced Nephrotoxicity.
    Rivera S
    Crit Care Nurs Clin North Am; 2022 Dec; 34(4):361-371. PubMed ID: 36336427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.